Total Payments
$36,483
2024 Payments
$13,867
Companies
14
Transactions
77
Medicare Patients
2,141
Medicare Billing
$263,668
Payment Breakdown by Category
Other$19,570 (53.6%)
Travel$8,625 (23.6%)
Consulting$4,200 (11.5%)
Food & Beverage$4,088 (11.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,570 | 9 | 53.6% |
| Travel and Lodging | $8,625 | 20 | 23.6% |
| Consulting Fee | $4,200 | 1 | 11.5% |
| Food and Beverage | $4,088 | 47 | 11.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $34,841 | 61 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $247.04 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $245.94 | 2 | $0 (2022) |
| Allergan Inc. | $206.51 | 2 | $0 (2019) |
| Inari Medical, Inc. | $165.11 | 1 | $0 (2023) |
| Alkermes, Inc. | $125.00 | 1 | $0 (2019) |
| Melinta Therapeutics, Inc. | $121.80 | 1 | $0 (2019) |
| ABBVIE INC. | $121.13 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $119.86 | 1 | $0 (2021) |
| PORTOLA PHARMACEUTICALS, INC. | $112.40 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,867 | 21 | Gilead Sciences, Inc. ($13,867) |
| 2023 | $21,139 | 41 | Gilead Sciences, Inc. ($20,973) |
| 2022 | $244.52 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($123.39) |
| 2021 | $178.57 | 2 | AstraZeneca Pharmaceuticals LP ($119.86) |
| 2019 | $471.58 | 6 | Alkermes, Inc. ($125.00) |
| 2018 | $582.45 | 5 | Allergan Inc. ($149.01) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $100.08 | General |
| 09/27/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,540.00 | General |
| Category: COVID-19 | ||||||
| 09/27/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $18.09 | General |
| Category: COVID-19 | ||||||
| 09/24/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: COVID-19 | ||||||
| 07/09/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: COVID-19 | ||||||
| 06/30/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $1,160.22 | General |
| Category: COVID-19 | ||||||
| 06/30/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: COVID-19 | ||||||
| 05/28/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: COVID-19 | ||||||
| 05/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $2,205.60 | General |
| Category: COVID-19 | ||||||
| 05/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $188.95 | General |
| Category: COVID-19 | ||||||
| 05/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $121.15 | General |
| Category: COVID-19 | ||||||
| 04/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $118.05 | General |
| 04/05/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $140.18 | General |
| Category: COVID-19 | ||||||
| 04/05/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: COVID-19 | ||||||
| 04/05/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $35.21 | General |
| Category: COVID-19 | ||||||
| 04/05/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: COVID-19 | ||||||
| 03/09/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $637.20 | General |
| Category: COVID-19 | ||||||
| 03/09/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $383.07 | General |
| Category: COVID-19 | ||||||
| 03/09/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $48.19 | General |
| Category: COVID-19 | ||||||
| 03/09/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $48.04 | General |
| Category: COVID-19 | ||||||
| 02/23/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,810.00 | General |
| Category: COVID-19 | ||||||
| 12/22/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $17.03 | General |
| Category: COVID-19 | ||||||
| 12/21/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,540.00 | General |
| Category: COVID-19 | ||||||
| 12/19/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $120.74 | General |
| Category: COVID-19 | ||||||
| 12/13/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $87.72 | General |
| Category: COVID-19 | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 221 | 285 | $96,766 | $24,058 |
| 2022 | 5 | 354 | 534 | $172,272 | $43,291 |
| 2021 | 7 | 820 | 1,228 | $387,728 | $101,462 |
| 2020 | 7 | 746 | 1,070 | $351,898 | $94,858 |
Total Patients
2,141
Total Services
3,117
Medicare Billing
$263,668
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 79 | 118 | $42,490 | $10,782 | 25.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 67 | 68 | $23,440 | $5,467 | 23.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 74 | $17,712 | $4,623 | 26.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $13,124 | $3,186 | 24.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 111 | 203 | $62,697 | $16,391 | 26.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 64 | 65 | $38,736 | $9,094 | 23.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 81 | 163 | $35,045 | $9,027 | 25.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 83 | 88 | $27,710 | $7,090 | 25.6% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $8,084 | $1,688 | 20.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 249 | 477 | $147,821 | $38,547 | 26.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 120 | 123 | $73,951 | $18,984 | 25.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 193 | 218 | $69,229 | $18,389 | 26.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 155 | 303 | $63,555 | $17,259 | 27.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 37 | 37 | $20,297 | $4,761 | 23.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 40 | 44 | $9,409 | $2,433 | 25.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 26 | 26 | $3,467 | $1,090 | 31.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 237 | 436 | $138,173 | $37,128 | 26.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 128 | 130 | $79,811 | $21,633 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 153 | 262 | $56,112 | $15,345 | 27.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 158 | 169 | $54,047 | $14,439 | 26.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 26 | 26 | $14,506 | $3,836 | 26.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 32 | 35 | $7,629 | $1,972 | 25.8% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Facility | 2020 | 12 | 12 | $1,620 | $505.60 | 31.2% |
About Dr. Adeel Mikael, MD
Dr. Adeel Mikael, MD is a Internal Medicine healthcare provider based in Temple Terrace, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1114238581.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adeel Mikael, MD has received a total of $36,483 in payments from pharmaceutical and medical device companies, with $13,867 received in 2024. These payments were reported across 77 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,570).
As a Medicare-enrolled provider, Mikael has provided services to 2,141 Medicare beneficiaries, totaling 3,117 services with total Medicare billing of $263,668. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist, Hospitalist
- Location Temple Terrace, FL
- Active Since 06/30/2010
- Last Updated 12/16/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114238581
Products in Payments
- Veklury (Drug) $34,502
- ELIQUIS (Drug) $258.18
- FLOWTRIEVER CATHETER, S (Device) $165.11
- AVYCAZ (Drug) $149.01
- VIVITROL (Drug) $125.00
- JARDIANCE (Drug) $123.39
- OFEV (Drug) $122.55
- Orbactiv (Drug) $121.80
- DALVANCE (Drug) $121.13
- LOKELMA (Drug) $119.86
- BEVYXXA (Drug) $112.40
- XARELTO (Drug) $73.49
- YUPELRI (Drug) $58.71
- TEFLARO (Drug) $57.50
- Quadra Assura CRT Defibrillator (Device) $34.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Temple Terrace
Dr. Amit Johnsingh, Md, MD
Internal Medicine — Payments: $54,638
Internal Medicine $54,638
Dr. Ammer Haffar, Md, MD
Internal Medicine — Payments: $4,131
Internal Medicine $4,131
Charles Lambert, Md, MD
Internal Medicine — Payments: $4,118
Internal Medicine $4,118
Ronald Barbour, Md, MD
Internal Medicine — Payments: $4,025
Internal Medicine $4,025
Ketheeswaran Kathiripillai, Md, MD
Internal Medicine — Payments: $1,984
Internal Medicine $1,984
Saima Iqbal, M.d, M.D
Internal Medicine — Payments: $1,564
Internal Medicine $1,564